Name | GSK3145095 |
---|
Description | GSK3145095 is a RIP1 kinase inhibitor with an IC50 of 6.3 nM [1]. |
---|---|
Related Catalog | |
Target |
IC50: 6.3 nM (RIP1 kinase )[1] |
In Vitro | GSK3145095 potently blocks the TNF response as shown by determination of overall cell viability as measured by cellular ATP levels (IC50 = 1.6 nM), cell death as measured by LDH release (IC50 = 0.5 nM) and RIP1-dependent inflammatory cytokine MIP-1β production, either as absolute levels for protein, or fold changes in mRNA expression (IC50 = 0.4 nM) [1]. |
References |
Molecular Formula | C20H17F2N5O2 |
---|---|
Molecular Weight | 397.38 |